Unfractionated and low-molecular-weight heparin for hypercoagulability in dogs and cats - Veterinary Medicine
  • SEARCH:
Medicine Center
DVM Veterinary Medicine Featuring Information from:

ADVERTISEMENT

Unfractionated and low-molecular-weight heparin for hypercoagulability in dogs and cats
A new type of heparin, low-molecular-weight heparin, shows promise as an effective and easier-to-use form of therapy for people prone to thromboembolism. Does the same hold true for dogs and cats?


VETERINARY MEDICINE


16. Hirsh J, Levine MN. Low molecular weight heparin. Blood 1992;79:1-17.

17. Hirsh J, Warkentin TE, Raschke R, et al. Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety. Chest 1998;114 (5 suppl):489S-510S. [Erratum in: Chest 1999;115:1760.]

18. Hopper K, Bateman S. An updated view of hemostasis: mechanisms of hemostatic dysfunction associated with sepsis. J Vet Emerg Crit Care 2005;15:83-91.

19. Good LI, Manning AM. Thromboembolic disease: physiology of hemostasis and pathophysiology of thrombosis. Compend Contin Educ Pract Vet 2003;25:650-659.

20. Roncales FJ, Sancho JM. Coagulation activators. In: Feldman BF, Zinkl JG, Jain NC, eds. Schalm's veterinary hematology. 5th ed. Philadelphia, Pa: Lippincott, Williams & Wilkins, 2000;532-537.

21. Luchtman-Jones L, Broze GJ Jr. The current status of coagulation. Ann Med 1995;27:47-52.

22. Di Nisio M, Middeldorp S, Buller HR. Direct thrombin inhibitors. N Engl J Med 2005;353:1028-1040. [Erratum in: N Engl J Med 2005;353:2827.]

23. Johnstone IB. Coagulation inhibitors. In: Feldman BF, Zinkl JG, Jain NC, eds. Schalm's veterinary hematology. 5th ed. Philadelphia, Pa: Lippincott, Williams, & Wilkins, 2000;538-542.

24. Darien BJ. Acquired coagulopathy V: thrombosis. In: Feldman BF, Zinkl JG, Jain NC, eds. Schalm's veterinary hematology. 5th ed. Philadelphia, Pa: Lippincott, Williams & Wilkins, 2000;574-580.

25. McNicol PL, Liu G, Harley ID, et al. Patterns of coagulopathy during liver transplantation: experience with the first 75 cases using thromboelastography. Anaest Intensive Care 1994;22:659-665.

26. Allwood AJ, Downend AB, Slensky KA, et al. Evaluation of thromboelastography (TEG) in normal cats (abst.). J Vet Emerg Crit Care 2004;14:S1.

27. Verstraete M. Heparin and thrombosis: a seventy year long story. Haemostasis 1990;20 (suppl 1):4-11.

28. Harenberg J. Pharmacology of low molecular weight heparins. Semin Thromb Hemost 1990;16 Suppl:12-18.

29. Breuhl EL, Scott-Moncrief C, Brooks MB. A prospective study of unfractionated heparin therapy to prevent thrombosis in canine immune-mediated hemolytic anemia (abst). J Vet Intern Med 2005;19:399-400.

30. Fryer JS, McMichael MA, Slater MR. Effect of heparin use on survival to discharge of dogs with immune mediated hemolytic anemia (abst). J Vet Intern Med 2005;19:400.

31. Braz-Ruivo L. Thromboembolic disease in cats. In: Mathews KA. Veterinary emergency and critical care manual. Guelph, Ontario: Lifelearn, 2006;194-197.

32. Mischke RH, Schuttert C, Grebe SI. Anticoagulant effects of repeated subcutaneous injections of high doses of unfractionated heparin in healthy dogs. Am J Vet Res 2001;62:1887-1891.


ADVERTISEMENT

Source: VETERINARY MEDICINE,
Click here